Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer
NCT00006038 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2013-06-19
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving chemotherapy drugs in different ways may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy followed by surgery and intraperitoneal chemotherapy in treating patients who have locally advanced stomach cancer.
Conditions
- Esophageal Cancer
- Gastric Cancer
Interventions
- DRUG
- DRUG
- DRUG
-
floxuridine
- DRUG
- DRUG
-
leucovorin calcium
- PROCEDURE
-
conventional surgery
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Memorial Sloan Kettering Cancer Center
lead OTHER
Principal Investigators
-
David Paul Kelsen, MD · Memorial Sloan Kettering Cancer Center
Study Design
- Purpose
- TREATMENT
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-02-29
- Primary Completion
- 2003-02-28
- Completion
- 2003-02-28
Countries
- United States
Study Locations
More Related Trials
-
High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer
NCT00002722 ·Status: COMPLETED ·Phase: PHASE2
-
Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid Tumor
NCT00711243 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Combination Chemotherapy in Treating Patients With Advanced Stomach, Gastroesophageal, or Esophageal Cancer
NCT01928290 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer
NCT00004873 ·Status: COMPLETED ·Phase: PHASE2
-
Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers
NCT00848783 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
NCT00515411 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer
NCT00003862 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer
NCT00003298 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer
NCT00003172 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery
NCT00011960 ·Status: COMPLETED ·Phase: PHASE2
-
Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer
NCT00002615 ·Status: COMPLETED ·Phase: PHASE3
-
Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer
NCT00004099 ·Status: TERMINATED ·Phase: PHASE3
-
Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach
NCT00003237 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy Alone vs. Chemotherapy + Surgical Resection in Patients With Limited-metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction
NCT02578368 ·Status: COMPLETED ·Phase: PHASE3
-
Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer
NCT06028737 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer
NCT00005060 ·Status: COMPLETED ·Phase: PHASE3
-
Multicenter Study to Perioperative Chemotherapy for Resectable Adenocarcinoma in Gastric Cancer
NCT01160419 ·Status: UNKNOWN ·Phase: PHASE2
-
Neoadjuvant Nab-Paclitaxel Plus Oxaliplatin, S-1, and Sintilimab in Early-Onset Resectable Gastric Cancer
NCT07018063 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach Cancer
NCT00134095 ·Status: UNKNOWN ·Phase: PHASE2
-
Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer
NCT00103103 ·Status: TERMINATED ·Phase: PHASE2
-
Paclitaxel and Irinotecan in Advanced Gastric Cancer
NCT01136031 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer
NCT00006081 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Study of Neoadjuvant Taxotere, Cisplatin, and 5-Fluorouracil in Patients With Gastric or Gastroesophageal Junction Adenocarcinoma
NCT00763646 ·Status: UNKNOWN ·Phase: PHASE2
-
Transarterial Neoadjuvant Chemotherapy vs.Traditional Intravenous Chemotherapy For Locally Advanced Gastric Cancer With SOX+PD-1
NCT05593458 ·Status: RECRUITING ·Phase: PHASE3
-
Phase I/II Study of Paclitaxel Plus CPT-11 in Pts. With 2nd Line Chemotherapy of Inoperable or Recurrent GC.
NCT00209612 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2